Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

astrazeneca a/s - budesonid - inhalationspulver - 200 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

astrazeneca a/s - budesonid - inhalationspulver - 400 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - budesonid - inhalationspulver - 100 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - budesonid - inhalationspulver - 200 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - budesonid - inhalationspulver - 400 mikrogram/dosis

Europese Unie - Deens - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - fedme - antiobesity preparations, excl. diætprodukter - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

mcneil denmark aps - budesonid - næsespray, suspension - 64 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - budesonid - inhalationspulver - 100 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - budesonid - næsespray, suspension - 64 mikrogram/dosis

Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - budesonid - næsespray, suspension - 64 mikrogram/dosis